MIMPARA 1 mg, granules in a capsule to be opened 30 capsules
Active ingredients: Cinacalcet hydrochloride, Cinacalcet
Commercialized according to BDPMDispensing in France: Prescription only
Granules in capsules30 capsulesorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- MIMPARA 1 mg, granulés en gélule à ouvrir
- Pharmaceutical form
- granulés en gélule
- Route of administration
- orale
- Presentation description
- 1 flacon polyéthylène haute densité (PEHD) de 30 gélule(s)
- Marketing authorisation holder
- AMGEN EUROPE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 30 Sept 2025
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
61326733CIP73014361CIP133400930143612Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CINACALCETgélule | 1 mg · une gélule | FT |
| CHLORHYDRATE DE CINACALCETgélule | — | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.